Two Platforms for Next Generation Biomarker Discovery
A Single Picture Does Not Say It All: A Case for Comprehensive Biomarker Use in Cancer Research
During the Virtual Biomarkers Congress Eitan Akirav presented A Single Picture Does Not Say It All, a case for comprehensive biomarker use within oncology research. Did you miss out on his presentation during the conference? Now you can submit the form below to watch it at your own leisure!
In Situ Multiplex Analysis of Resident Microglia and Infiltrating Macrophages in Glioblastoma
Multiplex Immunofluorescence Detection of Resident Memory T Cells in Solid Tumors
Protein Biomarkers Overview
With some therapeutics proving ineffective in as many as 75% of patients, the need for precision medicine is clear, as is the benefit of using selection biomarkers in the drug development process where success rates can triple. In the era of personalized and precision medicine, we have expanded our portfolio beyond the routine safety and efficacy parameters in order to deliver value. We are committed to providing a full repertoire of next-generation assays.
Cerba Research can provide either targeted approaches or broad immune profiling and multifactorial biomarker approaches to identify one or a variety of biomarkers, depending on the stage of your clinical trial and the purpose of the biomarker.
To find out more from our library, click here
Find out more by downloading our Protein Biomarkers overview.